Form D — REGENTIS BIOMATERIALS LTD.

0001213900-26-072125 · filed Jun 25, 2026

Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.

Check this disclosure on SEC EDGAR · More Biotechnology filings

Offering

Industry: Biotechnology
Exemptions: 06c
Reported offering amount: $6,500,000
Reported amount sold: $6,500,000
Minimum investment: $0
Investors: 22
Sales commission: $455,000
Finders' fees: $0

Issuer

Name: REGENTIS BIOMATERIALS LTD.
CIK: 1912966
Entity: Corporation
Jurisdiction: ISRAEL
Year incorporated: —
Address: 60 MEDINAT HAYEHUDIM STREET
HERZLIYA, L3 4676652
Phone: +972 (9) 960-1917

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Ehud Geller · Executive Officer

Herzliya, L3 Find on LinkedIn ↗
Ori Gon · Executive Officer

Herzliya, L3 Find on LinkedIn ↗
Arie Gordashnikov · Executive Officer

Herzliya, L3 Find on LinkedIn ↗
Galit Reske · Executive Officer

Herzliya, L3 Find on LinkedIn ↗
Jeff Dykan · Director

Herzliya, L3 Find on LinkedIn ↗
Keith Valentine · Director

Herzliya, L3 Find on LinkedIn ↗
Efraim Cohen-Arazi · Director

Herzliya, L3 Find on LinkedIn ↗
Pini Ben-Elazar · Director

Herzliya, L3 Find on LinkedIn ↗
Susan Alpert · Director

Herzliya, L3 Find on LinkedIn ↗

View the original filing on SEC EDGAR ↗